MJH News January 2020
Post Views: 2,078
toto togel situs togel togel online toto togel situs slot link togel slot online togel online toto togel situs togel situs toto toto togel situs toto kawijitu situs toto kawijitu toto slot situs toto toto online situs slot situs toto slot gacor kawijitu Post Views: 2,340
By Allison Shelton and Elizabeth Jepson, Brown & Fortunato, P.C. Health care providers typically have some discretion in determining whether an incident is reportable under the Health Insurance Portability and Accountability Act (HIPAA). However, providers should take care in exercising such discretion. As evidenced by a recent settlement between a hospital system and the Office for Civil Rights (OCR), a provider’s decision to not report an incident, may result in significant costs. Subject to certain exceptions,...
By A. Kevin Troutman, Partner, Fisher Phillips At the dawn of a new year, experts agree that human resources professionals in the health care industry face daunting challenges. In fact, even the single most long-standing challenge now comes with new twists. Including huge hospital systems, neighborhood physician and dental practices, clinics, diagnostic centers and home health agencies, to name a few, the health care industry comprises a vast slice of the country’s economy...
By Ketan Patel, Advisory Principal, KPMG Healthcare Blockchain, cloud computing, advanced analytics, and remote monitoring are just some of the technologies presenting businesses worldwide with both challenges and opportunities. At this moment, they are especially resonating as opportunities with healthcare industry executives because – when brought together in various combinations – these technologies can offer powerful and detailed operational insights, especially relative to quality and cost of care. The ability of healthcare providers,...
By Ted Shaw, President/CEO, Texas Hospital Association With the start of a new year and a new decade, we reflect on our past achievements and challenges, and look forward to the promise of a new year. It’s an opportunity for a new beginning and a more refined focus. We take stock and plan new courses of action to better our lives, with resolutions to eat better, exercise more, and reduce stress. Texas hospitals, too,...
By Sagar Kamprath, MD, UTMB Fellow, Integrative and Behavioral Medicine Fellowship Program “A little starvation can really do more for the average sick man than can the best medicines and the best doctors.” -Mark Twain As a health care provider, I’ve come to appreciate the limited impact I can have on my patients through pills and procedures alone. In fact, I’ve come to agree with what was etched onto an ancient Egyptian pyramid...
Researchers at The University of Texas MD Anderson Cancer Center have identified a tenacious subset of immune macrophages that thwart treatment of glioblastoma with anti-PD-1 checkpoint blockade, elevating a new potential target for treating the almost uniformly lethal brain tumor. Their findings identify macrophages that express high levels of CD73, a surface enzyme that’s a vital piece of an immunosuppressive molecular pathway. The strong presence of the CD73 macrophages was unique to glioblastoma among five tumor...
Hydrogels for healing, synthesized from the molecules up by Rice University bioengineers, are a few steps closer to the clinic. Rice researchers and collaborators at Texas Heart Institute (THI) have established a baseline set of injectable hydrogels that promise to help heal wounds, deliver drugs, and treat cancer. Critically, they’ve analyzed how the chemically distinct hydrogels provoke the body’s inflammatory response — or not. Hydrogels developed at Rice are designed to be injectable and create a...
A study at The University of Texas MD Anderson Cancer Center demonstrated a potential new approach to treating two of the most common subtypes of lymphoma through manipulation of molecular programs controlled by the cAMP-response element-binding protein (CREBBP). Mutations of CREBBP are frequently found in follicular lymphoma and diffuse large B-cell lymphomas (DLBCL) and allow malignant cells to hide from the immune system. Co-lead investigators, Michael Green, Ph.D., assistant professor of Lymphoma & Myeloma at MD Anderson and Ari Melnick, M.D., of Weill Cornell Medical...